Showing posts with label Boehringer Ingelheim Philippines. Show all posts
Showing posts with label Boehringer Ingelheim Philippines. Show all posts

Sunday, August 9, 2026

Iwas Dialysis, Ligtas Kidneys brings early kidney health screening closer to Taytay residents

Taytay residents are taking proactive steps to protect their kidney health through accessible community-based screening efforts led by the local government in partnership with Boehringer Ingelheim Philippines. 

Chronic kidney disease (CKD) often develops silently, with many individuals unaware they have it until symptoms appear or the disease has progressed. In the Philippines, an estimated 13 million Filipinos, or 11.2% of the population, are living with CKD, underscoring the importance of early screening to identify risks sooner, access timely care, and help prevent further disease progression.

Friday, June 27, 2025

GPCCI RTD Highlights Urgency for Integrated Cardio-Renal-Metabolic Care in the PH

The German-Philippine Chamber of Commerce and Industry (GPCCI), in partnership with the German Embassy Manila and Boehringer Ingelheim Philippines, convened a multi-stakeholder roundtable discussion to address the pressing issue of cardio-renal-metabolic (CRM) health and explore strategies for more integrated and patient-centered care.

The roundtable brought together leaders and experts from medical associations, patient advocacy groups, academic institutions, and the pharmaceutical industry. Discussions focused on aligning efforts across sectors and government agencies to respond to the growing incidence of interconnected cardiovascular, renal, and metabolic conditions.

“Addressing CRM conditions is not only about clinical treatment. It is about equity, education, and empathy,” said Dr. Cherry Sevilla-Arenas, from the Philippine Heart Center on her keynote address. “Despite growing awareness, many patients continue to fall through the cracks due to uneven access and fragmented systems of care. If we want to move toward meaningful health outcomes, we must align our efforts—across government, industry, and communities—to prevent care fragmentation and ensure no Filipino is left behind.”